Log in to save to my catalogue

Natural-Product-Derived Adjunctive Treatments to Conventional Therapy and Their Immunoregulatory Act...

Natural-Product-Derived Adjunctive Treatments to Conventional Therapy and Their Immunoregulatory Act...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_0ba61abd99a04800a7ca2b3ca5e777cd

Natural-Product-Derived Adjunctive Treatments to Conventional Therapy and Their Immunoregulatory Activities in Triple-Negative Breast Cancer

About this item

Full title

Natural-Product-Derived Adjunctive Treatments to Conventional Therapy and Their Immunoregulatory Activities in Triple-Negative Breast Cancer

Publisher

Switzerland: MDPI AG

Journal title

Molecules (Basel, Switzerland), 2023-08, Vol.28 (15), p.5804

Language

English

Formats

Publication information

Publisher

Switzerland: MDPI AG

More information

Scope and Contents

Contents

Triple-negative breast cancer (TNBC) is an invasive and persistent subtype of breast cancer that is likely to be resistant to conventional treatments. The rise in immunotherapy has created new modalities to treat cancer, but due to high costs and unreliable efficacy, adjunctive and complementary treatments have sparked interest in enhancing the eff...

Alternative Titles

Full title

Natural-Product-Derived Adjunctive Treatments to Conventional Therapy and Their Immunoregulatory Activities in Triple-Negative Breast Cancer

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_0ba61abd99a04800a7ca2b3ca5e777cd

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_0ba61abd99a04800a7ca2b3ca5e777cd

Other Identifiers

ISSN

1420-3049

E-ISSN

1420-3049

DOI

10.3390/molecules28155804

How to access this item